Clinical Trial Update: Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the switch from sirolimus to everolimus in stable kidney transplant recipients not using calcineurin inhibitors, focusing on efficacy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Afinitor (everolimus)
• Rapamune (sirolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED